PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer (PREFER)
PREFER: PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer: A Randomized Control Trial
Sponsor: Reproductive Medicine Associates of New Jersey
Terminated
recruitment issues
Other terminated trials from Reproductive Medicine Associates of New Jersey
- Infertility · Phase NA · Dec 2021
- Infertility · Dec 2021
- Infertility, Female · Phase NA · Dec 2021
- Infertility of Uterine Origin · Phase NA · May 2021
- Male Infertility Due to Azoospermia · Jan 2021
See all terminations from Reproductive Medicine Associates of New Jersey
Other Infertility, Female trials with similar outcome
This NA trial investigates Infertility, Female and is currently terminated or withdrawn. Reproductive Medicine Associates of New Jersey leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Jun 2025 — Present [monthly]
Terminated NA
-
Mar 2025 — Jun 2025 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
First recorded
Oct 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Reproductive Medicine Associates of New Jersey
For direct contact, visit the study record on ClinicalTrials.gov .